» Articles » PMID: 26610338

Clinical Presentation of Infective Endocarditis Caused by Different Groups of Non-beta Haemolytic Streptococci

Overview
Publisher Springer
Date 2015 Nov 28
PMID 26610338
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococci are common causes of infective endocarditis (IE) and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has provided a practical tool for their species determination. We aimed to investigate if particular groups of non-beta heamolytic streptococci were associated with IE or to specific presentations thereof. The Swedish Registry of Infective Endocarditis was used to identify cases of IE caused by streptococci and a local database to identify cases of streptococcal bacteremia. The bacteria were grouped using MALDI-TOF MS and the clinical characteristics of IE caused by different groups were compared. We identified a group of 201 streptococcal IE isolates: 18 isolates belonged to the anginosus, 19 to the bovis, 140 to the mitis, 17 to the mutans, and seven to the salivarius groups. The mitis and mutans groups were significantly more common and the anginosus group less common among IE cases as compared to all cause bacteremia. Patients infected with the bovis group isolates were older, had more cardiac devices, and had more commonly prosthetic valve IE compared to IE caused by streptococci of the other groups. Twenty-one percent of patients needed surgery, and in-hospital mortality was 8% with no significant differences between the groups. Grouping of non-beta haemolytic streptococci using MALDI-TOF MS can provide a basis for decision-making in streptococcal bacteremia. IE caused by bovis group isolates have clinical characteristics distinguishing them from IE caused by other groups of Streptococcus.

Citing Articles

Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis.

Schellong P, Joean O, Pletz M, Hagel S, Weis S Drugs. 2024; 85(2):193-214.

PMID: 39720961 PMC: 11802659. DOI: 10.1007/s40265-024-02135-z.


Risk and Outcome of Infective Endocarditis in Streptococcal Bloodstream Infections according to Streptococcal Species.

Seo H, Hyun J, Kim H, Park S, Chung H, Bae S Microbiol Spectr. 2023; 11(4):e0104923.

PMID: 37284757 PMC: 10434186. DOI: 10.1128/spectrum.01049-23.


Platelet Activation and Aggregation Induced by Streptococcus bovisStreptococcus equinus Complex.

Pernow G, Shannon O, Oberg J, Nilson B, Rasmussen M Microbiol Spectr. 2022; 10(6):e0186122.

PMID: 36374116 PMC: 9769897. DOI: 10.1128/spectrum.01861-22.


Streptococcal infective endocarditis: clinical features and outcomes according to species.

Chamat-Hedemand S, Dahl A, Hassager C, Arpi M, Ostergaard L, Bundgaard H Infection. 2022; 51(4):869-879.

PMID: 36152224 DOI: 10.1007/s15010-022-01929-1.


Streptococcus constellatus Left Ventricular Apical Mural Infective Endocarditis With Acute Stroke, Septic and Cardiogenic Shock.

Hilker E, Patil S, Holliday Z, Arora N Cureus. 2022; 14(2):e22238.

PMID: 35340460 PMC: 8930438. DOI: 10.7759/cureus.22238.


References
1.
Senneby E, Nilson B, Petersson A, Rasmussen M . Matrix-assisted laser desorption ionization-time of flight mass spectrometry is a sensitive and specific method for identification of aerococci. J Clin Microbiol. 2013; 51(4):1303-4. PMC: 3666765. DOI: 10.1128/JCM.02637-12. View

2.
Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S . Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002; 288(1):75-81. DOI: 10.1001/jama.288.1.75. View

3.
PARKER M, Ball L . Streptococci and aerococci associated with systemic infection in man. J Med Microbiol. 1976; 9(3):275-302. DOI: 10.1099/00222615-9-3-275. View

4.
Sunnerhagen T, Nilson B, Olaison L, Rasmussen M . Clinical and microbiological features of infective endocarditis caused by aerococci. Infection. 2015; 44(2):167-73. DOI: 10.1007/s15010-015-0812-8. View

5.
Sunnerhagen T, Nilson B, Rasmussen M . Antibiotic synergy against viridans streptococci isolated in infective endocarditis. Int J Antimicrob Agents. 2015; 45(5):550-1. DOI: 10.1016/j.ijantimicag.2015.01.002. View